DAOREUANG KIDNEY: Open Payments
NPI 1114572294 · CASPER, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,610 in 74 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $583 · 2025 $1,610
Food & beverage: $1,559Education: $51
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $304 |
| ABBVIE INC. | 18 | $274 |
| Madrigal Pharmaceuticals | 7 | $246 |
| Janssen Biotech, Inc. | 8 | $227 |
| Regeneron Healthcare Solutions, Inc. | 10 | $195 |
| GENZYME CORPORATION | 2 | $60 |
| Lilly USA, LLC | 3 | $59 |
| Gilead Sciences, Inc. | 3 | $58 |
| PFIZER INC. | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
Products named: DUPIXENT, REZDIFFRA, TREMFYA, ENTYVIO, RINVOQ, EOHILIA, LINZESS, OMVOH.
Industry payments across WY — which companies pay providers there.
